NextFin News - Jana Partners is turning the screws on Alkami Technology again, pressing the board to consider a sale just as the digital banking software company is trying to prove that faster ARR growth and higher profitability can justify independence. Alkami reported second-quarter revenue of $129.8 million, adjusted EBITDA of $19.4 million, and annual recurring revenue of $511.7 million, then lifted full-year guidance to $528 million to $531 million in revenue and $96 million to $98 million in adjusted EBITDA. The stock last closed at $17.80, near the lower end of its recent trading band and still far below the highs it posted over the past year.
The clash now revolves around valuation, timing, and control. Jana’s case is not that Alkami has failed operationally. It is that the company may be worth more in a transaction than in a public-market rerating that could take several quarters, especially in a software segment where strategic buyers can assign a different value to recurring revenue, customer relationships, and product depth than investors willing to wait for multiple expansion. Alkami’s defense is the opposite: recent execution suggests the business is improving fast enough to close that gap on its own.
That makes the new letter more than another governance headline. It is an attempt to convert operating momentum into a process question. If the board opens the door to strategic alternatives, the stock can move on process alone. If it resists, the market will have to decide whether to keep paying for the standalone story or to keep discounting it until proof arrives.
What Jana Is Trying To Force
Jana’s renewed pressure is built on the same core argument activists use when they think the public market is underpricing a software platform: the company has enough scale, recurring revenue, and strategic relevance to be interesting to a buyer, but not enough market trust to trade at that value on its own. That is why the call for a sale matters. It is not a criticism of Alkami’s product or customer base. It is a claim that the value of those assets may be better realized in private hands.
Alkami has improved enough to make that argument harder to dismiss. In its second-quarter release on July 29, the company said revenue grew 15.9% year over year to $129.8 million, adjusted EBITDA reached $19.4 million, and ARR rose 21% to $511.7 million. Management also said it ended the quarter with 23.6 million digital banking users and guided 2026 revenue to $528 million to $531 million. Those are not the numbers of a company in trouble. They are the numbers of a company that is still growing while moving toward better profitability.
But that is exactly where the activist logic bites. A better operating profile does not always close a valuation gap. Sometimes it widens the case for a sale because the company has already done the work that makes it attractive to strategic buyers. Jana is effectively saying that the market may be paying too little for a platform that is becoming more profitable, more predictable, and more valuable inside a larger software or financial-technology portfolio.
The stock action reinforces that tension. ALKT last closed at $17.80, and the share has recently traded between $16.11 and $18.39. That range suggests investors are willing to assign some value to the improved fundamentals, but not enough to imply confidence that the company’s standalone path will be fully recognized near term. If the market believed the rerating story was already secure, the shares would not be hugging the lower half of that band while the company posts double-digit growth and guides to further margin expansion.
For Jana, that is the opening. The activist does not need to prove that Alkami is weak. It only needs to show that the board should not assume the public market will reward good execution quickly enough to maximize value. The gap between operating improvement and share-price response is the argument.
Why The Sale Case Is More Structural Than Cyclical
This is a structural dispute, not just a cyclical one. The cyclical version of the story would say software multiples have simply been compressed by rates, risk appetite, and sector rotation, and that a lower discount rate or a better market mood will eventually lift Alkami without any strategic transaction. That explanation is not wrong, but it is incomplete. The activist push matters because it suggests the discount is being driven by something stickier than macro sentiment alone.
Three features point in that direction. First, Alkami’s operating progress has been real, yet the share price still has not fully rerated. Revenue is growing, ARR is above $500 million, and adjusted EBITDA is moving higher, but the market continues to value the business cautiously. Second, the company sits in a consolidating bank-software niche, where strategic buyers can justify a value above what public investors are willing to pay for the same recurring cash flows. Third, the activist pressure itself indicates a belief that waiting for the market to catch up may not be enough.
That does not make the short-term move structural in a pure sense. Software stocks can still swing with broader risk appetite. But the mechanism that matters here is more durable than a single earnings cycle. A company with improving fundamentals can still trade like a “prove it” story if investors think the operating gains are not enough to remove execution risk. In that case, the market is not simply waiting for a quarter or two; it is waiting for a regime change in confidence. Jana is trying to shortcut that wait by forcing a strategic process.
The first-order effect of the letter is board pressure. The second-order effect is multiple pressure. If a sale process looks credible, investors may begin pricing the stock against takeover value rather than standalone earnings. If the board rejects the idea or drags out the process, the activist premium could fade and the shares could drift back toward a pure fundamentals valuation. That is the market transmission channel: process changes perception, and perception changes the multiple before any deal is signed.
“The market may still be assigning Alkami too little value for the company’s recurring revenue, improving profitability, and strategic relevance.”
That is the core bet Jana is making. The board may believe time will fix the valuation gap. The activist believes time may simply preserve it.
The strongest counter-thesis is equally serious: Alkami may be too early in its margin and ARR expansion to sell now. The company’s second-quarter results show the business is gaining traction, and management has now guided to a larger 2026 revenue and adjusted EBITDA base. If that trajectory continues, an independent Alkami could be worth more than a sale price struck before the full benefit of the operating model shows up in future results. In that view, Jana is trying to force the issue before the market has fully absorbed the compounding story.
The falsifying signal for Jana’s case would be a sequence of quarters in which Alkami continues to post revenue growth around the current range, keeps expanding ARR and adjusted EBITDA, and yet the shares still fail to re-rate even after broader software multiples recover. That would indicate the discount is not just about patience or macro conditions. It would mean the market is applying a deeper structural skepticism to the standalone model.
There is also an execution risk on the activist side. A sale review can absorb management time and create a binary setup that leaves investors disappointed if no bidder meets expectations. If the company runs a process and comes up empty, the market may end up focusing even more on near-term fundamentals. That is why Jana’s escalation is meaningful: it is a bet that the value of forcing a process outweighs the risk of not getting a deal.
What Happens Next
In the short term, the stock will trade on process rather than on a full fundamental reappraisal. Any sign that Alkami’s board is engaging with bidders, advisers, or new strategic alternatives could support the activist narrative and keep a premium in the shares. Any sign of pushback, delay, or a narrow defense of the company’s current path could unwind some of that premium quickly. This is the sentiment and liquidity layer of the story.
Over the medium term, the numbers remain the board’s best defense. If Alkami keeps revenue growing in the mid-teens, keeps ARR above the $500 million mark, and keeps adjusted EBITDA moving higher toward the upper end of guidance, management can argue that independence is still creating value. But that argument only holds if the market eventually rewards the performance. If the stock stays stuck in a narrow range while the business improves, the activist case gets stronger because the gap between execution and valuation becomes harder to ignore.
Over the long term, the real question is whether Alkami is a standalone compounder or a consolidating asset. In a consolidating software niche, strategic value often shows up before public-market confidence does. That means the board’s choice is not just about one quarter or even one year. It is about whether the company wants to let the market re-rate it slowly, or whether it wants to test what a buyer would pay for the same cash flows now.
The base case is that Jana’s pressure keeps the sale debate alive while Alkami continues to show progress on revenue and margin. The upside case is a credible strategic review that opens the door to a richer bid or a faster rerating. The downside case is a process that stalls, disappoints, and leaves the stock to trade on fundamentals alone.
Jana is not arguing that Alkami’s business is broken. It is arguing that good execution may still be too slow for the price the market is willing to pay.
Explore more exclusive insights at nextfin.ai.
